Vildagliptin promotes diabetic foot ulcer healing through autophagy modulation

被引:2
作者
Biros, Erik [1 ,2 ]
Vangaveti, Venkat [1 ,2 ]
Malabu, Usman [1 ,3 ]
机构
[1] James Cook Univ, Coll Med & Dent, Translat Res Endocrinol & Diabet, 1 James Cook Dr, Townsville, Qld 4811, Australia
[2] Townsville Univ Hosp, Townsville, Australia
[3] Townsville Univ Hosp, Dept Diabet & Endocrinol, Townsville, Australia
关键词
Diabetic foot ulcer; Vildagliptin; Wound fluid; Wound healing; Autophagy; INHIBITOR VILDAGLIPTIN; DEGRADATION; ACTIVATION;
D O I
10.1186/s13098-024-01444-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The study aimed to investigate the molecular mechanisms underlying the effects of Vildagliptin on the healing of diabetic foot ulcers (DFUs). The research compared patients who received 12 weeks of Vildagliptin treatment to those who did not. Various molecular markers associated with wound healing were measured. Wound fluid samples were collected from DFUs using a filter paper absorption technique, and total RNA was extracted for quantitative real-time PCR (qPCR). The results showed that the autophagy marker NUP62 was significantly downregulated in the Vildagliptin group at week 12 compared to baseline (median expression 0.57 vs. 1.28; P = 0.0234). No significant change was observed in the placebo group (median expression 1.61 vs. 1.48; P = 0.9102). Both groups showed substantial downregulation of RIPK3, a necroptosis marker, at week 12 compared to their respective baselines. In addition to its effects on blood sugar levels, Vildagliptin may promote DFU healing by reducing autophagy in patients with diabetes.
引用
收藏
页数:9
相关论文
共 27 条
[1]   The islet enhancer vildagliptin:: mechanisms of improved glucose metabolism [J].
Ahren, B. ;
Foley, J. E. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 :8-14
[2]   Vildagliptin, a DPP-4 Inhibitor, Attenuates Endothelial Dysfunction and Atherogenesis in Nondiabetic Apolipoprotein E-Deficient Mice [J].
Aini, Kunduziayi ;
Fukuda, Daiju ;
Tanaka, Kimie ;
Higashikuni, Yasutomi ;
Hirata, Yoichiro ;
Yagi, Shusuke ;
Kusunose, Kenya ;
Yamada, Hirotsugu ;
Soeki, Takeshi ;
Sata, Masataka .
INTERNATIONAL HEART JOURNAL, 2019, 60 (06) :1421-1429
[3]   An Overview of Diabetic Foot Ulcers and Associated Problems with Special Emphasis on Treatments with Antimicrobials [J].
Baig, Mirza Shahed ;
Banu, Ahmadi ;
Zehravi, Mehrukh ;
Rana, Ritesh ;
Burle, Sushil S. ;
Khan, Sharuk L. ;
Islam, Fahadul ;
Siddiqui, Falak A. ;
Massoud, Ehab El Sayed ;
Rahman, Md Habibur ;
Cavalu, Simona .
LIFE-BASEL, 2022, 12 (07)
[4]   The efficacy and safety of vildagliptin in patients with type 2 diabetes: a meta-analysis of randomized clinical trials [J].
Cai, L. ;
Cai, Y. ;
Lu, Z. J. ;
Zhang, Y. ;
Liu, P. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (04) :386-398
[5]   Microvascular dysfunction in diabetic foot disease and ulceration [J].
Chao, Clare Y. L. ;
Cheing, Gladys L. Y. .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2009, 25 (07) :604-614
[6]   Dipeptidyl peptidase-4 inhibition improves endothelial senescence by activating AMPK/SIRT1/Nrf2 signaling pathway [J].
Chen, Zhihui ;
Yu, Jing ;
Fu, Menglu ;
Dong, Ruolan ;
Yang, Yan ;
Luo, Jinlan ;
Hu, Shuiqing ;
Li, Wenhua ;
Xu, Xizhen ;
Tu, Ling .
BIOCHEMICAL PHARMACOLOGY, 2020, 177
[7]   Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system after first-time lower extremity revascularizations [J].
Darling, Jeremy D. ;
McCallum, John C. ;
Soden, Peter A. ;
Guzman, Raul J. ;
Wyers, Mark C. ;
Hamdan, Allen D. ;
Verhagen, Hence J. ;
Schermerhorn, Marc L. .
JOURNAL OF VASCULAR SURGERY, 2017, 65 (03) :695-704
[8]   Polypharmacy among people living with type 2 diabetes mellitus in rural communes in Vietnam [J].
Dieu Huyen Thi Bui ;
Bai Xuan Nguyen ;
Dat Cong Truong ;
Meyrowitsch, Dan Wolf ;
Sondergaard, Jens ;
Gammeltoft, Tine ;
Bygbjerg, Ib Christian ;
Jannie, Nielsen .
PLOS ONE, 2021, 16 (04)
[9]   Molecular definitions of autophagy and related processes [J].
Galluzzi, Lorenzo ;
Baehrecke, Eric H. ;
Ballabio, Andrea ;
Boya, Patricia ;
Pedro, Jose Manuel Bravo-San ;
Cecconi, Francesco ;
Choi, Augustine M. ;
Chu, Charleen T. ;
Codogno, Patrice ;
Isabel Colombo, Maria ;
Maria Cuervo, Ana ;
Debnath, Jayanta ;
Deretic, Vojo ;
Dikic, Ivan ;
Eskelinen, Eeva-Liisa ;
Fimia, Gian Maria ;
Fulda, Simone ;
Gewirtz, David A. ;
Green, Douglas R. ;
Hansen, Malene ;
Harper, J. Wade ;
Jaattela, Marja ;
Johansen, Terje ;
Juhasz, Gabor ;
Kimmelman, Alec C. ;
Kraft, Claudine ;
Ktistakis, Nicholas T. ;
Kumar, Sharad ;
Levine, Beth ;
Lopez-Otin, Carlos ;
Madeo, Frank ;
Martens, Sascha ;
Martinez, Jennifer ;
Melendez, Alicia ;
Mizushima, Noboru ;
Munz, Christian ;
Murphy, Leon O. ;
Penninger, Josef M. ;
Piacentini, Mauro ;
Reggiori, Fulvio ;
Rubinsztein, David C. ;
Ryan, Kevin M. ;
Santambrogio, Laura ;
Scorrano, Luca ;
Simon, Anna Katharina ;
Simon, Hans-Uwe ;
Simonsen, Anne ;
Tavernarakis, Nektarios ;
Tooze, Sharon A. ;
Yoshimori, Tamotsu .
EMBO JOURNAL, 2017, 36 (13) :1811-1836
[10]   Activation of Transient Receptor Potential Channel Vanilloid 4 by DPP-4 (Dipeptidyl Peptidase-4) Inhibitor Vildagliptin Protects Against Diabetic Endothelial Dysfunction [J].
Gao, Peng ;
Li, Li ;
Wei, Xiao ;
Wang, Miao ;
Hong, Yangning ;
Wu, Hao ;
Shen, Yanjia ;
Ma, Tianyi ;
Wei, Xing ;
Zhang, Qin ;
Fang, Xia ;
Wang, Lijuan ;
Yan, Zhencheng ;
Du, Guan-Hua ;
Zheng, Hongting ;
Yang, Gangyi ;
Liu, Daoyan ;
Zhu, Zhiming .
HYPERTENSION, 2020, 75 (01) :150-162